financetom
Business
financetom
/
Business
/
Sequoia Capital-backed Vanta raises funding at $2.45 billion valuation
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Sequoia Capital-backed Vanta raises funding at $2.45 billion valuation
Jul 24, 2024 5:36 AM

(Reuters) - Online security and compliance management platform Vanta said on Wednesday it had raised $150 million in a fresh funding round led by venture capital firm Sequoia Capital, giving it a valuation of $2.45 billion.

Companies pursuing artificial intelligence (AI) adoption are attracting the attention of U.S. venture capital firms after a near two-year lull driven by high interest rates and a sluggish exit market for startup investors.

Vanta says it wants to double down on its AI innovation, eliminate legacy tools in compliance and deepen its global presence by venturing into the UK and Australia.

The venture capital businesses of banking giants Goldman Sachs and JPMorgan Chase also participated in the round that saw all previous investors returning, bringing the lifetime raise of the company to $353 million since 2021.

San Francisco-based Vanta raised $50 million in 2021 in a round led by Sequoia Capital, which also participated in its fundraise the year after. The company achieved a valuation of $1.6 billion when it raised $110 million in 2022.

The company has more than 8,000 customers, including Microsoft-owned developer platform GitHub, hiring platform SmartRecruiters and database company ZoomInfo.

Vanta, founded in 2018 by CEO Christina Cacioppo, helps its clients with security monitoring and achieving compliance certifications at a faster pace through process automation.

"We're investing in Vanta because of their demonstrated platform approach, starting with automated compliance and rapidly adding new modules," said Goldman Sachs growth equity investor Mike Reilly.

Atlassian Ventures, Craft Ventures, CrowdStrike Ventures, HubSpot Ventures, Workday Ventures and Y Combinator were the other investors in the funding round.

(Reporting by Pritam Biswas in Bengaluru; Editing by Devika Syamnath)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Honda Motor Reportedly Expects to Double EV Driving Range Before Decade Ends
Honda Motor Reportedly Expects to Double EV Driving Range Before Decade Ends
Nov 21, 2024
06:54 AM EST, 11/21/2024 (MT Newswires) -- Honda Motor ( HMC ) is looking to double the driving range of its electric cars by the late 2020s when they start to mass produce all-solid-state batteries, media outlets reported Wednesday. All-solid-state batteries are expected to produce twice the driving range by the end of 2030 and over 2.5 times more by...
RTX's Pratt & Whitney to Explore Upgrading F100 Engine Maintenance, Overhaul Capacity
RTX's Pratt & Whitney to Explore Upgrading F100 Engine Maintenance, Overhaul Capacity
Nov 21, 2024
07:13 AM EST, 11/21/2024 (MT Newswires) -- RTX (RTX) subsidiary Pratt & Whitney said Thursday it has signed a letter of intent with Wojskowe Zaklady Lotnicze to explore an expansion of maintenance repair and overhaul capabilities to meet increased Polish Air Force needs for the F100 engines powering its F-16 fleet. No financial details were disclosed. Piotr Owsicki, general director...
Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
Zymeworks, Jazz Pharmaceuticals Receive FDA's Accelerated Approval for Ziihera to Treat Biliary Tract Cancer
Nov 21, 2024
07:12 AM EST, 11/21/2024 (MT Newswires) -- Zymeworks ( ZYME ) and Jazz Pharmaceuticals (JAZZ) said Thursday they have received accelerated approval for Ziihera from the US Food and Drug Administration to treat adult patients with previously-treated, unresectable or metastatic HER2-positive biliary tract cancer. The regulator's approval was based on the HERIZON-BTC-01 trial of Ziihera, which evaluated zanidatamab as a...
Alibaba Consolidates E-commerce Businesses Under Single Unit
Alibaba Consolidates E-commerce Businesses Under Single Unit
Nov 21, 2024
06:54 AM EST, 11/21/2024 (MT Newswires) -- Alibaba Group ( BABA ) said Thursday in a Hong Kong Stock Exchange filing that it has established Alibaba E-commerce Business Group that will consolidate its e-commerce businesses, including Taobao and Tmall Group, Alibaba International Digital Commerce Group, 1688 Marketplace, and Idle Fish. Alibaba ( BABA ) said the new group will oversee...
Copyright 2023-2026 - www.financetom.com All Rights Reserved